Evaluation of demographic characteristics and laboratory results of patients with Covid-19 treated in the intensive care unit

Basit Öğe Kaydı
dc.contributor.authorAydin, N.
dc.contributor.authorEsen, O.
dc.contributor.authorKarayalçin, U.
dc.date.accessioned2024-05-19T14:33:44Z
dc.date.available2024-05-19T14:33:44Z
dc.date.issued2022
dc.departmentİstinye Üniversitesien_US
dc.description.abstractWe aimed to investigate the clinical features, hemodynamic and respiratory profiles as well as prognostic outcomes of critically sick COVID-19 patients admitted to intensive care units (ICUs). This retrospective study was performed using data derived from 99 adult patients treated in the ICU. Demographic and clinical data as well as hemodynamic and respiratory profiles, therapeutic outcomes were recorded. The relationship between these features and ICU stay was sought. The average age was 65.94 ± 14.93 years (24 to 96), and 73 patients (73.7%) had comorbidities. Smokers constituted 13.1% of the Covid-19 patient population (n=13) in ICU. Thirty-one cases (31.3%) had received at least one dose of Covid-19 vaccine and 63 patients (63.6%) died in the ICU after their initial hospitalization. Blood products were utilized in 29 patients (29.3%) and delta mutation was detected in 23 (23.2%) of ICU patients. The mean duration of ICU stay was 16.90 ± 11.41 days (1 to 60). The duration of ICU stay was remarkably different between groups receiving different antibiotic regimens (p<0.001). There was no significant relationship between the duration of ICU stay and blood groups (p=0.052), systolic (p=0.572) and diastolic blood pressure (p=0.098) and initial arterial oxygen saturation (p=0.223). We detected a high mortality rate in our series with severe COVID-19 infection treated in ICU. These data are critical for understanding the impact of COVID-19 on our hospitals, identifying areas for clinical management improvement, and allowing for continuous international and temporal comparisons of COVID-19 patient outcomes. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.description.sponsorshipNo financial support or funding was received for this paper.en_US
dc.identifier.doi10.52142/omujecm.39.4.37
dc.identifier.endpage1142en_US
dc.identifier.issn1309-4483
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85142280386en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1134en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.4.37
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4322
dc.identifier.volume39en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240519_kaen_US
dc.subjectCovıd-19en_US
dc.subjectDemographicen_US
dc.subjectİntensive Care Uniten_US
dc.subjectLaboratoryen_US
dc.subjectTreatmenten_US
dc.titleEvaluation of demographic characteristics and laboratory results of patients with Covid-19 treated in the intensive care uniten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu